Citizens Maintains Market Outperform on BeOne Medicines, Raises Price Target to $463

Benzinga · 2d ago
Citizens analyst Reni J. Benjamin maintains BeOne Medicines (NASDAQ:ONC) with a Market Outperform and raises the price target from $405 to $463.